Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

200 terminated/withdrawn out of 1802 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

11%

193 trials in Phase 3/4

Results Transparency

45%

479 of 1069 completed trials have results

Key Signals

181 recruiting479 with results117 terminated83 withdrawn

Enrollment Performance

Analytics

N/A

757(52.9%)

Phase 2

286(20.0%)

Phase 1

160(11.2%)

Phase 4

118(8.2%)

Phase 3

75(5.2%)

Early Phase 1

35(2.4%)

1431Total

N/A(757)

Phase 2(286)

Phase 1(160)

Phase 4(118)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1802)

Showing 20 of 1802 trials

NCT01148056Not ApplicableTerminated

Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer

Role: collaborator

NCT07303816Phase 4Recruiting

Statins to Prevent Cancer Associated Blood Clots

Role: lead

NCT04633889Phase 2Active Not Recruiting

Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury

Role: lead

NCT05083455Active Not Recruiting

Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data

Role: lead

NCT04736420Active Not Recruiting

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Role: lead

NCT07464093Not ApplicableRecruiting

STABLE Pilates for Hypermobility

Role: lead

NCT04149600Active Not Recruiting

Identification of Genetic Causes of Calcific Aortic Valve Disease

Role: collaborator

NCT07599345Active Not Recruiting

Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data

Role: lead

NCT07417631Active Not Recruiting

Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

Role: lead

NCT07599384Active Not Recruiting

Emulation of the RECORD3 Trial Using Healthcare Claims Data

Role: lead

NCT07599293Active Not Recruiting

Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data

Role: lead

NCT07249840Phase 1Not Yet Recruiting

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Role: lead

NCT03579160Phase 2Terminated

Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes

Role: lead

NCT07619508Active Not Recruiting

Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.

Role: lead

NCT04777006Phase 4Completed

Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform

Role: collaborator

NCT07619495Active Not Recruiting

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Role: lead

NCT07136415Phase 4Recruiting

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Role: lead

NCT05498181Phase 2Completed

Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

Role: lead

NCT06569290Not ApplicableActive Not Recruiting

Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches

Role: lead

NCT06722287Not ApplicableRecruiting

Mobile Intervention for Mental Health of Family Caregivers in Thailand

Role: lead